These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1523845)

  • 1. Transcriptional overexpression of the proto-oncogene bcl-2 in patients with systemic Lupus erythematosus.
    Graninger WB
    Wien Klin Wochenschr; 1992; 104(7):205-7. PubMed ID: 1523845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional and post-transcriptional mechanisms are responsible for the increased expression of c-myc protooncogene in lymphocytes from patients with systemic lupus erythematosus.
    Eleftheriades EG; Boumpas DT; Balow JE; Tsokos GC
    Clin Immunol Immunopathol; 1989 Sep; 52(3):507-15. PubMed ID: 2474397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential oncogene and TNF-alpha mRNA expression in bone marrow cells from systemic lupus erythematosus patients.
    Alvarado-de la Barrera C; Alcocer-Varela J; Richaud-Patin Y; Alarcón-Segovia D; Llorente L
    Scand J Immunol; 1998 Nov; 48(5):551-6. PubMed ID: 9822266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High levels of bcl-2 protein in circulating T lymphocytes, but not B lymphocytes, of patients with systemic lupus erythematosus.
    Aringer M; Wintersberger W; Steiner CW; Kiener H; Presterl E; Jaeger U; Smolen JS; Graninger WB
    Arthritis Rheum; 1994 Oct; 37(10):1423-30. PubMed ID: 7945466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The bcl-2 proto-oncogene is overexpressed in systemic lupus erythematosus.
    Gatenby PA; Irvine M
    J Autoimmun; 1994 Oct; 7(5):623-31. PubMed ID: 7840854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased rate of apoptosis and decreased expression of bcl-2 protein in peripheral blood lymphocytes from patients with active systemic lupus erythematosus.
    Chan EY; Ko SC; Lau CS
    Asian Pac J Allergy Immunol; 1997 Mar; 15(1):3-7. PubMed ID: 9251841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine regulation of apoptosis and Bcl-2 expression in lymphocytes of patients with systemic lupus erythematosus.
    Graninger WB; Steiner CW; Graninger MT; Aringer M; Smolen JS
    Cell Death Differ; 2000 Oct; 7(10):966-72. PubMed ID: 11279543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced transcription of c-myc proto-oncogene in spleen lymphocytes from lupus-prone mice during the growing process.
    Deguchi Y; Kishimoto S
    FEBS Lett; 1989 Dec; 259(1):158-60. PubMed ID: 2689225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated expression of the Brn-3a and Brn-3b transcription factors in systemic lupus erythematosus correlates with antibodies to Brn-3 and overexpression of Hsp90.
    Ripley BJ; Rahman MA; Isenberg DA; Latchman DS
    Arthritis Rheum; 2005 Apr; 52(4):1171-9. PubMed ID: 15818685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and function of Fas antigen and bcl-2 in human systemic lupus erythematosus lymphocytes.
    Ohsako S; Hara M; Harigai M; Fukasawa C; Kashiwazaki S
    Clin Immunol Immunopathol; 1994 Oct; 73(1):109-14. PubMed ID: 7523011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bcl-2 oncogene (B cell lymphoma/leukemia-2) levels correlate with systemic lupus erythematosus disease activity.
    Miret C; Font J; Molina R; Garcia-Carrasco M; Filella X; Ramos M; Cervera R; Ballesta A; Ingelmo M
    Anticancer Res; 1999; 19(4B):3073-6. PubMed ID: 10652595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of c-cbl proto-oncogene is modulated during differentiation but not during induction of proliferation.
    Mushinski JF; Goodnight J; Rudikoff E; Morse HC; Langdon WY
    Oncogene; 1994 Sep; 9(9):2489-97. PubMed ID: 8058312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression and regulation of c-myb transcription in B6/lpr Lyt-2-, L3T4-T lymphocytes.
    Yokota S; Yuan D; Katagiri T; Eisenberg RA; Cohen PL; Ting JP
    J Immunol; 1987 Oct; 139(8):2810-7. PubMed ID: 3116095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical significance and expression of Bcl-2 protein in patients with systemic lupus erythematosus].
    Liu Y; Yin P; Zhao X; Shi C; Kong Q; Guan W
    Zhonghua Nei Ke Za Zhi; 1999 Feb; 38(2):94-7. PubMed ID: 11798633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of c-rel, from the NF-kappaB/Rel family, in T cells from patients with systemic lupus erythematosus.
    Burgos P; Metz C; Bull P; Pincheira R; Massardo L; Errázuriz C; Bono MR; Jacobelli S; González A
    J Rheumatol; 2000 Jan; 27(1):116-27. PubMed ID: 10648027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bcl-2 expression is unaltered in unfractionated peripheral blood mononuclear cells in patients with systemic lupus erythematosus.
    Rose LM; Latchman DS; Isenberg DA
    Br J Rheumatol; 1995 Apr; 34(4):316-20. PubMed ID: 7788144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody against chromatin assembly factor-1 is a novel autoantibody specifically recognized in systemic lupus erythematosus.
    Doe K; Nozawa K; Hiruma K; Yamada Y; Matsuki Y; Nakano S; Ogasawara M; Nakano H; Ikeda T; Ikegami T; Fujishiro M; Kawasaki M; Ikeda K; Amano H; Morimoto S; Ogawa H; Takamori K; Sekigawa I; Takasaki Y
    Lupus; 2014 Sep; 23(10):1031-41. PubMed ID: 24836587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of oncogenes (sFas, Bcl-2) and cytokines (IL-10, alfa-TNF) with the activity of systemic lupus erythematosus.
    Miret C; Font J; Molina R; Garcia-Carrasco M; Filella X; Ramos M; Cervera R; Ballesta A; Ingelmo M
    Anticancer Res; 2001; 21(4B):3053-9. PubMed ID: 11712810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenes and autoimmunity.
    Boumpas DT; Mark GE; Tsokos GC
    Anticancer Res; 1986; 6(3 Pt B):491-7. PubMed ID: 3527035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the BCL-2 gene locus as a susceptibility locus linked to the clinical expression of systemic lupus erythematosus (SLE).
    Huang QR; Morris D; Manolios N
    Rheumatol Int; 1996; 16(3):121-4. PubMed ID: 8893377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.